​

Aprea Therapeutics Ownership | Who Owns Aprea Therapeutics?

OverviewForecastFinancialsChart

Aprea Therapeutics Ownership Summary

Aprea Therapeutics is owned by 32.53% institutional investors, 11.75% insiders, and 55.72% retail investors. Nbc securities is the largest institutional shareholder, holding 0% of APRE shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.67% of its assets in Aprea Therapeutics shares.

APRE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAprea Therapeutics32.53%11.75%55.72%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nbc securities---
Princeton global asset management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nbc securities---
Princeton global asset management---

Top Buyers

HolderShares% AssetsChange
Princeton global asset management---100.00
Nbc securities---899.00

Top Sellers

HolderShares% AssetsChange
Nbc securities---899.00
Princeton global asset management---100.00

Sold Out

HolderChange
Princeton global asset management-100.00
Nbc securities-899.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202526-1,949,704-6.15%322.29%5-50.00%775.00%
Dec 31, 20242618.18%2,077,3813.81%373.32%1066.67%433.33%
Sep 30, 20241-899--3302.80%----
Jun 30, 20241-50.00%899-10.01%-2809.42%--100.00%--
Mar 31, 20242100.00%999899.00%-382025.93%1---

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF145.28K2.67%-
Vanguard Total Stock Mkt Idx Inv145.28K2.63%-
Vanguard Institutional Extnd Mkt Idx Tr28.56K0.52%-
Fidelity Extended Market Index24.41K0.44%-
DFA US Targeted Value I7.98K0.14%-
Fidelity Total Market Index7.20K0.13%-
Fidelity Series Total Market Index5.85K0.11%-
Dimensional US Targeted Value ETF3.52K0.06%-
Spartan Extended Market Index Pool F3.18K0.06%-
Spartan Extended Market Index Pool E2.95K0.05%212.00

Recent Insider Transactions

DateNameRoleActivityValue
Apr 03, 2025Gilad Oren President/CEOBuy$5.62K
Apr 03, 2025Gilad Oren President/CEOBuy$4.49K
Oct 18, 2024Duey Marc-Sell$29.58K
Oct 23, 2024Gilad Oren President/CEOBuy$1.96K
Oct 16, 2024Duey Marc-Buy$131.70K

Insider Transactions Trends

DateBuySell
2025 Q22-
2025 Q1--
2024 Q491
2024 Q2--
2024 Q112-

APRE Ownership FAQ

Who Owns Aprea Therapeutics?

Aprea Therapeutics shareholders are primarily institutional investors at 32.53%, followed by 11.75% insiders and 55.72% retail investors. The average institutional ownership in Aprea Therapeutics's industry, Biotech Stocks , is 64.05%, which Aprea Therapeutics falls below.

Does Blackrock own Aprea Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aprea Therapeutics.

Who is Aprea Therapeutics’s biggest shareholder by percentage of total assets invested?

Nbc securities is Aprea Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Aprea Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Aprea Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Aprea Therapeutics shares, with 2.67% of its total shares outstanding invested in 145.28K Aprea Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools